RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study

      한글로보기

      https://www.riss.kr/link?id=A105224181

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: Hypertriglyceridemia is known to have an association with increased risks of insulin resistance and diabetes. The aimof this study was to investigate the risk of diabetes mellitus, according to changes in the concentrations of triglyceride...

      Background: Hypertriglyceridemia is known to have an association with increased risks of insulin resistance and diabetes. The aimof this study was to investigate the risk of diabetes mellitus, according to changes in the concentrations of triglycerides, over time.
      Methods: A total of 15,932 non-diabetic participants (mean age 43.2 years, 68% men) who attended five consecutive annual healthcheck-ups at Kangbuk Samsung Hospital, between January 2010 and December 2014, were recruited. Participants were classifiedaccording to their triglyceride concentrations; normal (<150 mg/dL) and abnormal (≥150 mg/dL). According to the triglyceridelevels in 2010 and 2012, subjects were divided into four groups: normal-normal, normal-abnormal, abnormal-normal, and abnormalabnormal.
      The risk for incident diabetes was assessed in 2014.
      Results: Among the total subjects, 67.5% belonged to the normal-normal group, 8.6% to the normal-abnormal group, 9.4% to theabnormal-normal group, and 14.5% to the abnormal-abnormal group. A total of 234 subjects (1.5%) were newly diagnosed with diabetes,between 2010 and 2014. Over 4 years, 1%, 1.5%, 2.1%, and 3.0% of the subjects developed diabetes in the normal-normal,normal-abnormal, abnormal-normal, and abnormal-abnormal groups, respectively. When the risk for incident diabetes was analyzedin the groups, after adjusting the confounding variables, a 1.58-fold increase in the risk of diabetes (95% confidence interval [CI],1.10 to 2.26) was observed in the participants with persistent hypertriglyceridemia (abnormal-abnormal group). This was attenuatedby further adjustments for body mass index (BMI) (hazard ratio, 1.25; 95% CI, 0.86 to 1.80).
      Conclusion: In this large study population, persistent hypertriglyceridemia, over a period of 2 years, was significantly associatedwith the risk of incident diabetes, which was attenuated after adjustment for BMI.

      더보기

      참고문헌 (Reference)

      1 Abdul-Ghani MA, "What is the best predictor of future type 2 diabetes?" 30 : 1544-1548, 2007

      2 Seuring T, "The economic costs of type 2 diabetes: a global systematic review" 33 : 811-831, 2015

      3 Shah RV, "Statins and risk of new-onset diabetes mellitus" 126 : e282-e284, 2012

      4 Chogtu B, "Statin use and risk of diabetes mellitus" 6 : 352-357, 2015

      5 Warram JH, "Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents" 113 : 909-915, 1990

      6 Shimada A, "Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association" 15 : 57-, 2016

      7 Poitout V, "Regulation of the insulin gene by glucose and fatty acids" 136 : 873-876, 2006

      8 Ginsberg HN, "Regulation of plasma triglycerides in insulin resistance and diabetes" 36 : 232-240, 2005

      9 Tchernof A, "Pathophysiology of human visceral obesity: an update" 93 : 359-404, 2013

      10 Verges B, "Pathophysiology of diabetic dyslipidaemia: where are we?" 58 : 886-899, 2015

      1 Abdul-Ghani MA, "What is the best predictor of future type 2 diabetes?" 30 : 1544-1548, 2007

      2 Seuring T, "The economic costs of type 2 diabetes: a global systematic review" 33 : 811-831, 2015

      3 Shah RV, "Statins and risk of new-onset diabetes mellitus" 126 : e282-e284, 2012

      4 Chogtu B, "Statin use and risk of diabetes mellitus" 6 : 352-357, 2015

      5 Warram JH, "Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents" 113 : 909-915, 1990

      6 Shimada A, "Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association" 15 : 57-, 2016

      7 Poitout V, "Regulation of the insulin gene by glucose and fatty acids" 136 : 873-876, 2006

      8 Ginsberg HN, "Regulation of plasma triglycerides in insulin resistance and diabetes" 36 : 232-240, 2005

      9 Tchernof A, "Pathophysiology of human visceral obesity: an update" 93 : 359-404, 2013

      10 Verges B, "Pathophysiology of diabetic dyslipidaemia: where are we?" 58 : 886-899, 2015

      11 Hagman DK, "Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans" 280 : 32413-32418, 2005

      12 Roberts CK, "Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training" 3 : 1-58, 2013

      13 Rhee EJ, "Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study" 9 : e98369-, 2014

      14 Shimabukuro M, "Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression" 273 : 32487-32490, 1998

      15 Kruit JK, "Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules" 60 : 3186-3196, 2011

      16 Sommariva D, "Interrelationships between body mass and lipid and lipoprotein triglycerides and cholesterol in obese women" 16 : 481-488, 1986

      17 Cunha DA, "Initiation and execution of lipotoxic ER stress in pancreatic beta-cells" 121 : 2308-2318, 2008

      18 Rhee EJ, "Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: a nationwide population-based study" 12 : e0176615-, 2017

      19 Dotevall A, "Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study" 21 : 615-622, 2004

      20 Lillioja S, "Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians" 318 : 1217-1225, 1988

      21 Shaw JE, "Global estimates of the prevalence of diabetes for 2010 and 2030" 87 : 4-14, 2010

      22 Ginsberg HN, "Effects of statins on triglyceride metabolism" 81 : 32B-35B, 1998

      23 Bardini G, "Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and beta-cell dysfunction on micro- and macrovascular complications" 9 : 82-93, 2012

      24 Hao M, "Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction" 56 : 2328-2338, 2007

      25 Muacevic-Katanec D, "Diabetic dyslipidemia or 'diabetes lipidus'?" 9 : 341-348, 2011

      26 Schwartz KL, "Correlation of same-visit HbA1c test with laboratorybased measurements: a MetroNet study" 6 : 28-, 2005

      27 Sandhofer A, "Cholesteryl ester transfer protein in metabolic syndrome" 14 : 812-818, 2006

      28 Tirosh A, "Changes in triglyceride levels over time and risk of type 2 diabetes in young men" 31 : 2032-2037, 2008

      29 Seo MH, "Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study" 96 : E2050-E2054, 2011

      30 Gutch M, "Assessment of insulin sensitivity/resistance" 19 : 160-164, 2015

      31 Marathe PH, "American Diabetes Association standards of medical care in diabetes 2017" 9 : 320-324, 2017

      32 Galic S, "Adipose tissue as an endocrine organ" 316 : 129-139, 2010

      33 Ohn JH, "10-Year trajectory of ${\beta}$-cell function and insulin sensitivity in the development of type 2 diabetes: a communitybased prospective cohort study" 4 : 27-34, 2016

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-12-16 학술지명변경 한글명 : 대한내분비학회지 -> Endocrinology and Metabolism
      외국어명 : Endocrinology and Metabolism -> 미등록
      KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-06-28 학술지명변경 외국어명 : Journal of Korean Endocrin Society -> Endocrinology and Metabolism KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-06-05 학회명변경 영문명 : The Korean Society Of Endocrinology -> Korean Endocrin Society KCI등재
      2007-06-01 학술지명변경 외국어명 : Journal of Korean Society of Endocrinology -> Journal of Korean Endocrin Society KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.23 0.23 0.26
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.22 0.508 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼